Direct clinical trials of shockwave specifically for intercostal muscle injury are limited. The strongest evidence comes from broader myofascial and skeletal-muscle research, so treatment should be guided by diagnosis rather than extrapolated automatically from other regions.
The chest wall also adds safety considerations that other muscles do not. The lungs, heart and major vessels sit directly beneath it, and several look-alike problems, from rib fracture to slipping rib, need a completely different pathway.
What broader myofascial research shows
Evidence base
27 RCTs
595 participants receiving ESWT
Pain (VAS)
−1.7 cm
mean difference vs control, 95% CI −2.2 to −1.1
Pressure pain threshold
+1.1 kg/cm²
95% CI 0.4 to 1.7
Function
SMD −0.8
95% CI −1.6 to −0.04
PMID 37205742
High heterogeneity. This is broader myofascial evidence, not direct intercostal-specific proof.
Three levels of evidence
- Direct intercostal or rib-muscle data. A PubMed search combining intercostal, chest wall, costochondritis or slipping rib with shockwave terms returned blast-injury, urology and cardiac records, but no clinical trial of shockwave for intercostal or chest-wall muscle pain.
- Broader myofascial pain research. A 2024 meta-analysis of randomized trials provides the main clinical signal.
- Broader skeletal-muscle and mechanistic research. Muscle-injury reviews and fibrosis models offer biological plausibility.
None of these levels produces an intercostal-specific effect size.
The myofascial meta-analysis
A systematic review of randomized trials in myofascial pain found that ESWT reduced pain by an average 1.7 cm on a 10-cm visual analogue scale compared with control conditions and improved pressure-pain threshold and function. Heterogeneity was high, and ESWT was not clearly superior to several other active treatments.
The review included 27 randomized studies with 595 participants in the shockwave groups. Compared with control conditions, the mean difference in pain was −1.7 cm (95% CI −2.2 to −1.1), pressure pain threshold improved by 1.1 kg/cm² (95% CI 0.4 to 1.7), and function improved with a standardized mean difference of −0.8 (95% CI −1.6 to −0.04). No differences were found between shockwave and dry needling, exercise, injections or laser (Avendaño-López, 2024).
This is broader myofascial evidence, not intercostal-specific proof. The review did not report results for the intercostal muscles specifically. The chest wall's anatomy, and the thin muscle layer over the lungs between the ribs, mean those results cannot simply be transferred.
Broader muscle-injury research
Broader skeletal-muscle research also supports ESWT as a promising adjunct after muscle injury, but direct intercostal-specific effect sizes remain unavailable. A systematic review of eight studies involving 143 adults reported encouraging outcomes in individual studies, with only two randomized trials (Mazin, 2023). The details are covered in shockwave for chronic muscle injury and fibrosis.
Chronic muscle and connective-tissue changes
Muscle that heals after a significant strain can be left with altered connective tissue. In an experimental skeletal-muscle fibrosis model, radial shockwave combined with ultrashort-wave diathermy reduced fibrosis and lowered profibrotic signaling (Huang, 2021), and human scar-derived fibroblasts exposed to shockwave showed reduced expression of fibrosis-related molecules (Cui, 2018). These are mechanistic findings, not proof of tissue change in a human intercostal muscle. Chronic rib-region pain is not assumed to be fibrosis; the biology is reviewed in muscle fibrosis after a strain.
What manual therapy can and cannot do
Manual treatment may improve local tissue mobility and thoracic mechanics when the diagnosis is muscular or mechanically restricted soft tissue. It should not be used as a substitute for structural or medical evaluation when the problem is fracture, rib instability or non-musculoskeletal disease.
In a rat overuse model, modeled manual therapy reduced collagen and TGF-β1 deposition in fibrotic connective tissue while improving function (Bove, 2016), and in human muscle biopsies, massage activated mechanotransduction signaling after exercise-induced muscle damage (Crane, 2012). Those findings show manual treatment is biologically active in muscle; they do not show it changes intercostal tissue specifically.
In practice, manual treatment may address intercostal and surrounding muscle mobility, the thoracic spine and rib-joint mechanics, overlying fascia and breathing mechanics. It does not repair a rib fracture, permanently stabilize a slipping rib or substitute for medical evaluation of chest pain. Manual Adhesion Release may be part of the plan when the exam supports it.
When shockwave is not used
Shockwave is not a treatment for:
- Slipping rib syndrome; shockwave does not correct pathological rib hypermobility and should not be used as a substitute for dynamic diagnosis
- A suspected or confirmed rib fracture or stress injury
- Costochondritis as a generic indication
- Pneumothorax, pleural disease or any other intrathoracic problem
- Unexplained chest pain that has not been medically assessed
- Nerve-related pain from the thoracic spine or intercostal nerve
See slipping rib syndrome and dynamic ultrasound and intercostal strain vs. rib and chest-wall pain.
Safety around the thorax
Shockwave around the thorax requires careful anatomical selection and should only be applied to appropriate superficial musculoskeletal targets. Treatment is directed at accessible muscle such as the posterior or lateral chest-wall muscles over bone, with low energy and careful positioning. It is not aimed between the ribs into the lung, over the heart or major vessels, or across the front of the chest indiscriminately, and high-energy focused treatment is not fired through the chest wall.
Who might be a candidate
The candidates are a narrow group: people with persistent, localized muscular or myofascial pain of the chest wall or upper back whose medical screen is clear, in whom fracture, slipping rib, nerve pain and thoracic spine referral have been considered, and whose symptoms have not settled with graded breathing and trunk loading. Typical complaints are a tender band of muscle along the side or back of the rib cage that is provoked by rotation or reaching.
Questions to answer first
- Is the presentation consistent with a mechanical source, with cardiopulmonary causes addressed?
- Is the pain coming from muscle rather than a rib joint, cartilage, nerve or bone?
- Has slipping rib syndrome been considered, with dynamic ultrasound if suspected?
- Has a structured breathing, rotation and loading program been tried?
- Is the target superficial, over bone and away from the lung and heart?
What a session involves
When shockwave is used on the chest wall or upper back, sessions are short and use low energy on a carefully localized, superficial muscular target over bone. Intensity is adjusted to tolerance, and breathing comfort, rotation and focal tenderness are rechecked at follow-up visits. Because there is no intercostal-specific protocol, the number of sessions is individualized and judged against progress. New breathlessness, chest pain, bruising or worsening symptoms are a reason to stop and seek medical review.
Why the evidence gap matters
Without intercostal-specific trials, nobody can say how much benefit to expect for this region, how many sessions are needed or which settings are best. That uncertainty is a reason to reserve shockwave for clear muscular diagnoses that have not responded to loading, to keep the target conservative, and to set expectations honestly.
Where treatment fits with rehabilitation
Rehabilitation is the foundation. It typically progresses from pain-limited breathing to controlled deep breathing, trunk rotation and side bending, anti-rotation work, loaded rotation, rowing and pulling, and finally golf, throwing or other sport-specific movement. Manual treatment or shockwave, when used, supports that progression rather than replacing it.
How progress is judged
Progress is measured by function: comfortable deep breathing, coughing and sneezing, rotation and side-bending range, tolerance of pushing, pulling and sport-specific movement, and reduced focal tenderness. If those measures are not improving after a reasonable course, the diagnosis is revisited.
The bottom line
Shockwave may be considered for selected chronic muscular or myofascial chest-wall pain after fracture, rib instability, pulmonary disease and other competing diagnoses have been excluded. Direct intercostal-specific evidence remains limited, so ESWT should be positioned as a selective adjunct rather than a default treatment for rib pain.
How Novo uses this evidence
We screen for medical causes, localize the pain, test breathing, rotation and loading, consider fracture, slipping rib and nerve sources, and use dynamic ultrasound or other imaging when needed. When a muscular problem is confirmed and loading alone has not been enough, manual treatment or radial shockwave on an appropriate superficial target may be added. See how we approach rib, thoracic and intercostal pain.
References
- Avendaño-López C, Megía-García Á, Beltran-Alacreu H, et al. Efficacy of extracorporeal shockwave therapy on pain and function in myofascial pain syndrome: a systematic review and meta-analysis of randomized clinical trials. American Journal of Physical Medicine & Rehabilitation. 2024;103(2):89-98. PMID 37205742. (link)
- Mazin Y, Lemos C, Paiva C, Amaral Oliveira L, Borges A, Lopes T. The role of extracorporeal shock wave therapy in the treatment of muscle injuries: a systematic review. Cureus. 2023;15(8):e44196. PMID 37767244. (link)
- Huang PP, Zhang QB, Zhou Y, et al. Effect of radial extracorporeal shock wave combined with ultrashort wave diathermy on fibrosis and contracture of muscle. American Journal of Physical Medicine & Rehabilitation. 2021;100(7):643-650. PMID 32969968. (link)
- Cui HS, Hong AR, Kim JB, et al. Extracorporeal shock wave therapy alters the expression of fibrosis-related molecules in fibroblast derived from human hypertrophic scar. International Journal of Molecular Sciences. 2018;19(1):124. PMID 29301325. (link)
- Bove GM, Harris MY, Zhao H, Barbe MF. Manual therapy as an effective treatment for fibrosis in a rat model of upper extremity overuse injury. Journal of the Neurological Sciences. 2016;361:168-180. PMID 26810536. (link)
- Crane JD, Ogborn DI, Cupido C, et al. Massage therapy attenuates inflammatory signaling after exercise-induced muscle damage. Science Translational Medicine. 2012;4(119):119ra13. PMID 22301554. (link)
